Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17976237

Download in:

View as

General Info

PMID
17976237